✦ LIBER ✦

6509 ORAL Management of hypertension (HTN) in patients with advanced or recurrent non-squamous non-small cell lung cancer (NSCLC) receiving first-line cisplatin and gemcitabine with bevacizumab or placebo – results from randomised phase III trial BO17704

✍ Scribed by Bennouna, J.; vonPawel, J.; Zatloukal, P.; Ramlau, R.; Gorbounova, V.; Hirsh, V.; Leighl, N.; Mezger, J.; Moore, N.; Manegold, C.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

6503 ORAL Efficacy and safety results fr

✍ Manegold, C.; vonPawel, J.; Zatloukal, P.; Ramlau, R.; Gorbounova, V.; Hirsh, V. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 58 KB

6518 ORAL Subgroup results from a random

✍ Eberhardt, W.; Reck, M.; vonPawel, J.; Zatloukal, P.; Ramlau, R.; Gorbounova, V. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 57 KB

9003 ORAL Biomarker Analysis in BO21015,

✍ Mok, T.; Gorbunova, V.; Juhasz, E.; Szima, B.; Burdaeva, O.; Yu, C.J.; Delmar, P 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 43 KB

Efficacy of bevacizumab with cisplatin a

✍ Tony SK MOK; Te-Chun HSIA; Chun-Ming TSAI; Kenneth TSANG; Gee-Chen CHANG; John W 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 202 KB

PCN80 THE BENEFITS OF BEVACIZUMAB PLUS C

✍ MJ Nuijten; C Holmberg; S Walzer 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB

6570 POSTER Results for progression-free

✍ Sandler, A.; Reck, M.; vonPawel, J.; Zatloukal, P.; Ramlau, R.; Gorbounova, V.; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 58 KB